Edition:
India

Anthera Pharmaceuticals Inc (ANTH.OQ)

ANTH.OQ on NASDAQ Stock Exchange Capital Market

0.34USD
1:30am IST
Change (% chg)

$0.01 (+2.17%)
Prev Close
$0.33
Open
$0.34
Day's High
$0.35
Day's Low
$0.33
Volume
197,742
Avg. Vol
377,495
52-wk High
$3.36
52-wk Low
$0.30

Latest Key Developments (Source: Significant Developments)

Anthera Pharma's Board Approves Personnel Reorganization Plan
Tuesday, 17 Apr 2018 

April 16 (Reuters) - Anthera Pharmaceuticals Inc ::ANTHERA PHARMACEUTICALS INC - BOARD APPROVED & COMMENCED A MANAGEMENT & ADMINISTRATIVE PERSONNEL REORGANIZATION PLAN.ANTHERA PHARMACEUTICALS - PLANS TO ELIMINATE NON-ESSENTIAL SALARIED POSITIONS, WITH MAJORITY OF ELIMINATIONS OCCURRING BETWEEN APRIL 15 & APRIL 30, 2018.ANTHERA PHARMACEUTICALS INC - CO EXPECTS TO RECORD EXIT CHARGES, IN FORM OF TERMINATION BENEFITS OF ABOUT $1.2 MILLION.ANTHERA PHARMACEUTICALS - DECIDED TO ELIMINATE POSITIONS OF CHIEF MEDICAL OFFICER, & SENIOR VP, MANUFACTURING & POSITION OF SENIOR VP, MEDICAL SCIENCES.  Full Article

Anthera Pharmaceuticals Reports Top Line Data From Result Phase 3 Clinical Study Of Sollpura
Monday, 12 Mar 2018 

March 12 (Reuters) - Anthera Pharmaceuticals Inc ::ANTHERA PHARMACEUTICALS REPORTS TOP LINE DATA FROM THE RESULT PHASE 3 CLINICAL STUDY OF SOLLPURA.ANTHERA PHARMACEUTICALS INC - ‍SOLLPURA DID ACHIEVE SECONDARY ENDPOINT OF COEFFICIENT OF NITROGEN ABSORPTION​.ANTHERA PHARMACEUTICALS INC - SOLLPURA DID NOT ACHIEVE PRIMARY ENDPOINT OF COEFFICIENT OF FAT ABSORPTION.ANTHERA PHARMACEUTICALS INC - FURTHER DEVELOPMENT OF SOLLPURA TO BE DISCONTINUED.ANTHERA PHARMACEUTICALS INC - ‍ANTHERA TO EVALUATE ALL STRATEGIC ALTERNATIVES​.  Full Article

683 Capital Management Reports 6.1 Pct Passive Stake In Anthera Pharma
Friday, 19 Jan 2018 

Jan 18 (Reuters) - 683 Capital Management Llc :683 CAPITAL MANAGEMENT, LLC REPORTS A 6.1 PERCENT PASSIVE STAKE IN ANTHERA PHARMACEUTICALS INC AS OF JAN 8 - SEC FILING.  Full Article

Anthera Pharmaceuticals files for resale of up to 28.6 million shares of co's common stock
Tuesday, 14 Nov 2017 

Nov 13 (Reuters) - Anthera Pharmaceuticals Inc ::Anthera Pharmaceuticals Inc files for resale of up to 28.6 million shares of co's common stock by the selling stockholders‍​ .  Full Article

ANTHERA PHARMA REPORTS Q3 LOSS PER SHARE $0.58
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Anthera Pharmaceuticals Inc ::ANTHERA PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND REPORTS 2017 THIRD QUARTER FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.58.‍ENDED Q3 OF 2017 WITH CASH AND CASH EQUIVALENTS TOTALING $6.1 MILLION, COMPARED TO $20.8 MILLION AS OF DECEMBER 31, 2016​.  Full Article

Anthera Pharmaceuticals announces pricing of $15 mln private placement offering
Tuesday, 24 Oct 2017 

Oct 24 (Reuters) - Anthera Pharmaceuticals Inc :Anthera Pharmaceuticals announces pricing of $15 million private placement offering.Anthera Pharma - ‍To use net proceeds from offering for clinical research, development purposes for Sollpura, including result, simplicity, easy trials​.Anthera Pharmaceuticals Inc - ‍Investors have agreed to purchase 2.31 million shares of common stock at $1.25 per share​.  Full Article

Anthera announces positive DSMB review in phase 3 solution study of Sollpura
Tuesday, 16 Aug 2016 

Anthera Pharmaceuticals Inc : Announces positive DSMB review in phase 3 solution study of Sollpura .DSMB had "no concerns regarding safety of data to date, and voted that study continue without modification to protocol or charter.".  Full Article

Anthera Pharmaceuticals Q2 loss per share $0.35
Tuesday, 9 Aug 2016 

Anthera Pharmaceuticals Inc : Q2 loss per share $0.35 .Anthera Pharmaceuticals provides business update and reports 2016 second quarter financial results.  Full Article

Anthera Pharmaceuticals posts Q1 loss of $0.29/share
Monday, 9 May 2016 

Anthera Pharmaceuticals Inc : Anthera Pharmaceuticals provides business update and reports 2016 first quarter financial results . Q1 loss per share $0.29 .Says license and collaborative revenues for quarter ended March 31, 2016 totaled $145,000.  Full Article

BRIEF-Anthera Pharma's Board Approves Personnel Reorganization Plan

* ANTHERA PHARMACEUTICALS INC - BOARD APPROVED & COMMENCED A MANAGEMENT & ADMINISTRATIVE PERSONNEL REORGANIZATION PLAN